Clinical Neurology NewsPimavanserin found modestly effective in phase 2 Alzheimer’s psychosis studyNovember 14, 2017Alzheimer's & Cognition
Neurology ReviewsEarly Data Suggest Benefit of Aducanumab in Alzheimer’s DiseaseNovember 14, 2017Alzheimer's & Cognition
Neurology ReviewsMasitinib May Provide Clinical Benefits for Patients with ALSNovember 14, 2017Rare Diseases
Clinical Neurology NewsDirect oral anticoagulants okay during AF device placementNovember 14, 2017Stroke
Clinical Neurology NewsSalivary biomarker identified for Huntington’s diseaseNovember 13, 2017Movement DisordersRare DiseasesHuntington's Disease
Clinical Neurology NewsNarcolepsy drug has potential to help Parkinson’s disease sleep problemsNovember 13, 2017Movement DisordersSleep Medicine
Clinical Neurology NewsFormer pharma exec nominated for top HHS postNovember 13, 2017Business of Medicine
Clinical Neurology NewsDelay predicting outcome in comatose cardiac arrestNovember 13, 2017Neurosurgery & Trauma
Neurology ReviewsVirtual House Calls Are Feasible for Patients With Parkinson’s DiseaseNovember 13, 2017Parkinson's DiseaseMovement Disorders
Clinical Neurology NewsFDA approves Vimpat for POS treatment in children with epilepsyNovember 13, 2017Epilepsy & SeizuresPediatrics
Clinical Neurology NewsMACRA Monday: Documenting current medicationsNovember 13, 2017Business of Medicine
Clinical Neurology NewsUnblinded data show extent of verubecestat’s failure in mild-moderate Alzheimer’sNovember 12, 2017Alzheimer's & Cognition
Clinical Neurology NewsAmyloid imaging changed management for 80% of patients with uncertain dementia diagnosisNovember 9, 2017Alzheimer's & Cognition
Clinical Neurology NewsPublic health hazard: Bring your flu to work dayNovember 8, 2017Business of Medicine
